Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
8.72
+0.27 (3.20%)
Jun 15, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $34.86 | Buy | Initiates | $34.86 | +299.82% | May 20, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.31 | Buy | Maintains | $22.31 | +155.89% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.34 | Buy | Reiterates | $15.34 | +75.92% | May 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $19.52 | Buy | Reiterates | $19.52 | +123.90% | May 5, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.52 | Buy | Maintains | $19.52 | +123.90% | Apr 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26.50 | Buy | Maintains | $26.50 | +203.87% | Apr 1, 2026 |